Apatinib, a novel VEGFR-2 tyrosine kinase inhibitor, for relapsed and refractory nasopharyngeal carcinoma: data from an open-label, single-arm, exploratory study

Efficacy, Safety, and Pharmacokinetics of Axitinib in Nasopharyngeal Carcinoma: A Preclinical and Phase II Correlative Study

(2018) Edwin P. Hui et al.   CLINICAL CANCER RESEARCH

Antitumor Activity of Nivolumab in Recurrent and Metastatic Nasopharyngeal Carcinoma: An International, Multicenter Study of the Mayo Clinic Phase 2 Consortium (NCI-9742)

(2018) Brigette B.Y. Ma et al.   JOURNAL OF CLINICAL ONCOLOGY

Endostar Combined with Gemcitabine and Cisplatin Chemotherapy for Patients with Metastatic Nasopharyngeal Carcinoma: an Update

(2018) Ting Jin et al.   Translational Oncology

Progress in the treatment of solid tumors with apatinib: a systematic review

(2018) Deze Zhao et al.   OncoTargets and Therapy

The efficacy and safety of apatinib for refractory malignancies: a review and meta-analysis

(2018) Dantong Sun et al.   OncoTargets and Therapy

Safety and Antitumor Activity of Pembrolizumab in Patients With Programmed Death-Ligand 1–Positive Nasopharyngeal Carcinoma: Results of the KEYNOTE-028 Study

(2017) Chiun Hsu et al.   JOURNAL OF CLINICAL ONCOLOGY

Apatinib for metastatic breast cancer in non-clinical trial setting: Satisfying efficacy regardless of previous anti-angiogenic treatment

(2017) Ying Lin et al.   TUMOR BIOLOGY

Pre-emptive and therapeutic adoptive immunotherapy for nasopharyngeal carcinoma: Phenotype and effector function of T cells impact on clinical response

(2017) Corey Smith et al.   OncoImmunology

Efficacy and safety for Apatinib treatment in advanced gastric cancer: a real world study

(2017) Yong Zhang et al.   Scientific Reports

A phase II study of apatinib, a highly selective inhibitor of VEGFR-2, in patients with metastatic solid tumors without standard treatment options

(2016) Y-K. Kang et al.   ANNALS OF ONCOLOGY

Apatinib in Advanced Gastric Cancer: A Doubtful Step Forward

(2016) Lorenzo Fornaro et al.   JOURNAL OF CLINICAL ONCOLOGY

Apatinib in treatment of refractory gastric cancer

(2016) Vicki Brower   LANCET ONCOLOGY

Individualized treatment in stage IVC nasopharyngeal carcinoma

(2014) Oscar S.H. Chan et al.   ORAL ONCOLOGY

Multicenter phase II study of capecitabine combined with nedaplatin for recurrent and metastatic nasopharyngeal carcinoma patients after failure of cisplatin-based chemotherapy

(2013) Pei-Jian Peng et al.   CANCER CHEMOTHERAPY AND PHARMACOLOGY

Treatment outcome of docetaxel, capecitabine and cisplatin regimen for patients with refractory and relapsed nasopharyngeal carcinoma who failed previous platinum-based chemotherapy

(2013) Yan Gao et al.   EXPERT OPINION ON PHARMACOTHERAPY

A Phase II Study of Pazopanib in Asian Patients with Recurrent/Metastatic Nasopharyngeal Carcinoma

(2011) Wan-Teck Lim et al.   CLINICAL CANCER RESEARCH

Inhibition of Vascular Endothelial Growth Factor Receptor Signal Transduction Blocks Follicle Progression but Does Not Necessarily Disrupt Vascular Development in Perinatal Rat Ovaries1

(2009) Renee M. McFee et al.   BIOLOGY OF REPRODUCTION